Reese Pharmaceutical, a privately held manufacturer of over-the-counter (OTC) branded and private label products today announced ColoTest®,...
early detection
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
2 min read
On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated in Harbin, Heilongjiang province, China, marking...
A novel canine cancer study funded by Morris Animal Foundation and the Golden Retriever Foundation® is leveraging artificial intelligence to...
As reported in today’s issue of the journal Metabolites, researchers at Metabolomycs, a California-based biotechnology company, for the first time...
Reese Pharmaceutical is expanding its over-the-counter (OTC) diagnostic portfolio with the launch of ColoTest®, an at-home Fecal Immunochemical Test...
ImpediMed, a pioneer in the field of medical technology, announced a significant advancement in the fight against...
November is Oral Cancer Action Month, and Babylon Dental Care wants to emphasize the importance of early...
As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung...
VESICA HEALTH, INC., a multi-omics, liquid biopsy company transforming the management of hematuria patients and improving the...
With an unwavering commitment to raising awareness and driving meaningful action, Ikris Pharma has announced the highly...
